On Monday, Regenxbio Inc (NASDAQ: RGNX) was -8.68% drop from the session before settling in for the closing price of $7.83. A 52-week range for RGNX has been $5.62 – $21.57.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 87.87%. When this article was written, the company’s average yearly earnings per share was at 83.78%. With a float of $45.20 million, this company’s outstanding shares have now reached $49.55 million.
Considering the fact that the conglomerate employs 353 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 49.84%, operating margin of -277.51%, and the pretax margin is -272.54%.
Regenxbio Inc (RGNX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Regenxbio Inc stocks. The insider ownership of Regenxbio Inc is 9.76%, while institutional ownership is 86.27%. The most recent insider transaction that took place on Dec 30 ’24, was worth 148,504. Before that another transaction happened on Oct 01 ’24, when Company’s Director sold 10,000 for $10.11, making the entire transaction worth $101,052. This insider now owns 11,286 shares in total.
Regenxbio Inc (RGNX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 83.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.63% during the next five years compared to -12.18% drop over the previous five years of trading.
Regenxbio Inc (NASDAQ: RGNX) Trading Performance Indicators
You can see what Regenxbio Inc (RGNX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.64, a number that is poised to hit 0.46 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Regenxbio Inc (RGNX)
Compared to the last year’s volume of 0.98 million, its volume of 0.69 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 39.32%. Additionally, its Average True Range was 0.60.
During the past 100 days, Regenxbio Inc’s (RGNX) raw stochastic average was set at 23.18%, which indicates a significant decrease from 37.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.84% in the past 14 days, which was higher than the 79.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.39, while its 200-day Moving Average is $9.87. Nevertheless, the first resistance level for the watch stands at $7.48 in the near term. At $7.81, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.17. If the price goes on to break the first support level at $6.80, it is likely to go to the next support level at $6.44. Should the price break the second support level, the third support level stands at $6.11.
Regenxbio Inc (NASDAQ: RGNX) Key Stats
There are 50,086K outstanding shares of the company, which has a market capitalization of 358.11 million. As of now, sales total 83,330 K while income totals -227,100 K. Its latest quarter income was 21,210 K while its last quarter net income were -51,190 K.
